Add to ORKGBackground In many patients today, elective percu-taneous transluminal coronary angioplasty is followed by implantation of coronary stents to achieve optimal results. The current medical strategy to prevent early reocclusion is the inhibition of platelet aggregation by administration of ticlopidine, in addition to aspirin, immediately after the procedure. In order to inhibit platelet aggregation as early as possible, many centres begin to treat patients with additional ticlopidine the day before elective coronary intervention. The aim of this study was to determine the eVect of this strategy on platelet aggregation before angioplasty. Method Fifty-two consecutive patients admitted to hospi-tal for elective balloon angioplasty were prospecti...
Abstract Background Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y12 blocker is curre...
Background-Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more ef...
BACKGROUND: Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more e...
Previous studies indicate that percutaneous transluminal coronary angioplasty (PTCA) is associated w...
The effects of a premedication of aspirin and ticlopidine combined with an increased use of coronary...
Background—Platelet inhibition at the time of a percutaneous coronary intervention has consistently ...
AbstractObjectives. It is unknown whether a therapeutic combination of aspirin (ASA) and ticlopidine...
Background—Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly amo...
BACKGROUND: Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly am...
Background—Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly amo...
Background—Abciximab and ticlopidine reduce adverse cardiovascular events after percutaneous translu...
BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y12 blocker is currently sta...
AbstractObjectives. This study sought to investigate the contribution of ticlopidine to the inhibiti...
Item does not contain fulltextBACKGROUND: Activated platelets play a major role in acute vessel clos...
BACKGROUND: Platelet activation plays a major role in acute vessel closure after coronary angioplast...
Abstract Background Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y12 blocker is curre...
Background-Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more ef...
BACKGROUND: Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more e...
Previous studies indicate that percutaneous transluminal coronary angioplasty (PTCA) is associated w...
The effects of a premedication of aspirin and ticlopidine combined with an increased use of coronary...
Background—Platelet inhibition at the time of a percutaneous coronary intervention has consistently ...
AbstractObjectives. It is unknown whether a therapeutic combination of aspirin (ASA) and ticlopidine...
Background—Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly amo...
BACKGROUND: Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly am...
Background—Inhibition of platelet aggregation after aspirin or clopidogrel intake varies greatly amo...
Background—Abciximab and ticlopidine reduce adverse cardiovascular events after percutaneous translu...
BACKGROUND: Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y12 blocker is currently sta...
AbstractObjectives. This study sought to investigate the contribution of ticlopidine to the inhibiti...
Item does not contain fulltextBACKGROUND: Activated platelets play a major role in acute vessel clos...
BACKGROUND: Platelet activation plays a major role in acute vessel closure after coronary angioplast...
Abstract Background Dual antiplatelet therapy (DAPT) with aspirin (ASP) and a P2Y12 blocker is curre...
Background-Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more ef...
BACKGROUND: Dual therapy with ticlopidine and aspirin has been shown to be as effective as or more e...